Rankings
▼
Calendar
ALT FY 2006 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$318M
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
$1M
65.1% margin
Net Income
$1M
55.0% margin
EPS (Diluted)
$21.71
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$72M
Total Liabilities
$15M
Stockholders' Equity
$57M
Cash & Equivalents
$675,305
← FY 2007
All Quarters